LifeStance Health Group, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 280.6 million compared to USD 229.4 million a year ago. Net loss was USD 45 million compared to USD 46.7 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.86 USD | -3.65% | +3.00% | -12.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.39% | 2.62B | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.23% | 12.42B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- LFST Stock
- News LifeStance Health Group, Inc.
- LifeStance Health Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023